Go back

2013

• Situational Analysis of Cervical Cancer Prevention and Control in the Caribbean
  

  This report summarizes the results of a recent assessment of non-Latin Caribbean country policies and services for cervical cancer prevention and control.   It is intended to provide a snapshot of the currently available services and capacity, and to serve as a reference for program strengthening.  

2011

• PAHO. Workshop on VIA screening and cryotherapy treatment, Guatemala, 2011
  

  Although many countries of Latin America and the Caribbean (LAC) have been using cytology as a screening technique for over 30 years, cervical cancer is still the second most common malignant neoplasm in women of all ages in terms of incidence and mortality...

• PAHO. Progress in Cervical Cancer Prevention: The CCA Report Card, 2011
  

  Based on the laboratory work of Professor zur Hausen and his colleagues and critical Epidemiological studies of Dr. Nubia Muñoz and her colleagues, research over the past decades has shown infection with certain cancer-causing types of human papillomavirus (HPV) to be the necessary, but not sufficient, cause of cervical cancer.

• PAHO/PHAC. Preventing cervical cancer in Latin America. Project report, 2011
  

  Despite its preventable nature and availability of effective new technologies, cervical cancer remains among the leading causes of cancer deaths in women in Latin America and the Caribbean (LAC)...

2010

• PAHO. Report of the Latin American Subregional Meeting on Cervical Cancer Prevention - Panama, 2010
  

  Cervical cancer is the second most common malignant neoplasm in terms of incidence and mortality in women of all ages in the Latin American region. Each year, an estimated 63,068 women are diagnosed with cervical cancer in Latin America, with 29,222 deaths from this disease.

2009

• WHO. Meeting on HPV Vaccine Coverage and Impact Monitoring, Geneva, 2009
  

  A meeting on HPV Vaccine Coverage and Impact Monitoring was held at the World Health ganization (WHO) in Geneva, Switzerland on 16-17 November 2009 to discuss methods for HPV vaccine coverage monitoring and to further delineate objectives and strategies for HPV vaccine impact monitoring.

• WHO. Human Papillomavirus Vaccines, Position Statement, 2009 (En inglés)
  

  In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and vaccine combinations against diseases that have an international public health impact.

Go back